Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease

Dysbiosis is implicated by many studies in the pathogenesis of Parkinson’s disease (PD). Advances in sequencing technology and computing have resulted in confounding data regarding pathogenic bacterial profiles in conditions such as PD. Changes in the microbiome with reductions in short-chain fatty...

Descripción completa

Detalles Bibliográficos
Autores principales: Karunaratne, Tennekoon B., Okereke, Chijioke, Seamon, Marissa, Purohit, Sharad, Wakade, Chandramohan, Sharma, Amol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824468/
https://www.ncbi.nlm.nih.gov/pubmed/33374784
http://dx.doi.org/10.3390/nu13010028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824468/
https://www.ncbi.nlm.nih.gov/pubmed/33374784
http://dx.doi.org/10.3390/nu13010028

Ejemplares similares